Table 10.
L* | ||||
---|---|---|---|---|
CpLfe | Placebo | |||
Timing | Average ± SD | Average ∆% vs. Baseline | Average ± SD | Average ∆% vs. Baseline |
Baseline | 63.1 ± 0.7 | 62.5 ± 0.9 | ||
After 2-week treatment (T2w) | 63.8 ± 0.8 | 1.0% ** | 62.4 ± 0.8 | 0.00% |
After 4-week treatment (T4w) | 64.5 ± 0.7 | 2.2% *** | 62.8 ± 0.7 | 0.60% |
All differences between groups were statistically significant at T4w, p < 0.05 (ANOVA test). L* luminosity.